Highlights
NASDAQ: CLVS       Clovis Oncology Inc
Last Price Today's Change   Day's Range   Trading Volume
6.31   -0.24 (3.66%)  5.97 - 7.00  15,819,770

Overview

 
Avg Volume (4 weeks):8,239,890
4 Weeks Range:2.93 - 7.00
4 Weeks Price Volatility (%):
83.05%
52 Weeks Range:2.93 - 32.05
52 Weeks Price Volatility (%):
11.61%
Average Price Target: 26.50
Price Target Upside/Downside: +20.19

Headlines



No recent Headlines for this stock.


Business Background

Clovis Oncology Inc is operative in the healthcare sector based in the United States. As a pharmaceutical manufacturer, it is focused on developing and commercializing anti-cancer agents. Its suite of product candidates includes Rociletinib, Rucaparib and Lucitanib. Rociletinib is an oral epidermal growth factor receptor (EGFR), mutant-selective covalent inhibitor for the treatment of non-small cell lung cancer. Rucaparib is an oral inhibitor of poly (ADP-ribose) polymerase (PARP) that is in advanced clinical development for the treatment of ovarian cancer. The company's revenue primarily depends on the sale of Rucaparib in the United States market.

  Be the first to like this.
 


 

2999  2600  389  2989 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 FCEL 0.889+0.079 
 CHK 0.69-0.012 
 CSCO 44.91-3.55 
 AMD 38.35+0.83 
 CPE 4.19-0.27 
 AABA 19.630.00 
 NIO 1.75-0.15 
 NOK 3.37-0.10 
 SNNA 0.27+0.11 
 BAC 32.70-0.09 
Partners & Brokers